Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome: Past, Present, and Future.
10.3803/EnM.2015.30.4.456
- Author:
Soo Hyun KIM
1
Author Information
1. Molecular Cell Sciences Research Centre, St. George's Medical School, University of London, London, United Kingdom. skim@sgul.ac.uk
- Publication Type:Review
- Keywords:
Hypogonadism;
Kallmann syndrome;
Puberty;
Olfaction disorders;
Infertility;
Gonadotropins
- MeSH:
Adolescent;
Counseling;
Diagnosis;
Ear;
Genetic Testing;
Gonadotropin-Releasing Hormone;
Gonadotropins;
Heart;
Humans;
Hypogonadism*;
Infertility;
Kallmann Syndrome*;
Kidney;
Mental Competency;
Neurosecretory Systems;
Olfaction Disorders;
Phenotype;
Puberty;
Sequence Analysis, DNA;
Sexual Maturation;
Signal Transduction;
Skeleton;
Smell;
Axis, Cervical Vertebra
- From:Endocrinology and Metabolism
2015;30(4):456-466
- CountryRepublic of Korea
- Language:English
-
Abstract:
The proper development and coordination of the hypothalamic-pituitary-gonadal (HPG) axis are essential for normal reproductive competence. The key factor that regulates the function of the HPG axis is gonadotrophin-releasing hormone (GnRH). Timely release of GnRH is critical for the onset of puberty and subsequent sexual maturation. Misregulation in this system can result in delayed or absent puberty and infertility. Congenital hypogonadotropic hypogonadism (CHH) and Kallmann syndrome (KS) are genetic disorders that are rooted in a GnRH deficiency but often accompanied by a variety of non-reproductive phenotypes such as the loss of the sense of smell and defects of the skeleton, eye, ear, kidney, and heart. Recent progress in DNA sequencing technology has produced a wealth of information regarding the genetic makeup of CHH and KS patients and revealed the resilient yet complex nature of the human reproductive neuroendocrine system. Further research on the molecular basis of the disease and the diverse signal pathways involved will aid in improving the diagnosis, treatment, and management of CHH and KS patients as well as in developing more precise genetic screening and counseling regime.
